HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer.

AbstractINTRODUCTION:
Adjuvant treatment with tamoxifen substantially improves survival of women with estrogen-receptor positive (ER+) tumors. Tamoxifen resistance (TAMR) limits clinical benefit. RRR-α-tocopherol ether-linked acetic acid analogue (α-TEA) is a small bioactive lipid with potent anticancer activity. We evaluated the ability of α-TEA in the presence of tamoxifen to circumvent TAMR in human breast cancer cell lines.
METHODS:
Two genotypically matched sets of TAM-sensitive (TAMS) and TAM-resistant (TAMR) human breast cancer cell lines were assessed for signal-transduction events with Western blotting, apoptosis induction with Annexin V-FITC/PI assays, and characterization of cholesterol-rich microdomains with fluorescence staining. Critical involvement of selected mediators was determined by using RNA interference and chemical inhibitors.
RESULTS:
Growth-factor receptors (total and phosphorylated forms of HER-1 and HER-2), their downstream prosurvival mediators pAkt, pmTOR, and pERK1/2, phosphorylated form of estrogen receptor-α (pER-α at Ser-167 and Ser-118, and cholesterol-rich lipid microdomains were highly amplified in TAMR cell lines and enhanced by treatment with TAM. α-TEA disrupted cholesterol-rich microdomains, acted cooperatively with TAM to reduce prosurvival mediators, and induced DR5-mediated mitochondria-dependent apoptosis via an endoplasmic reticulum stress-triggered pro-death pJNK/CHOP/DR5 amplification loop. Furthermore, methyl-β-cyclodextrin (MβCD), a chemical disruptor of cholesterol rich microdomains, acted cooperatively with TAM to reduce prosurvival mediators and to induce apoptosis.
CONCLUSIONS:
Data for the first time document that targeting cholesterol-rich lipid microdomains is a potential strategy to circumvent TAMR, and the combination of α-TEA + TAM can circumvent TAMR by suppression of prosurvival signaling via disruption of cholesterol-rich lipid microdomains and activation of apoptotic pathways via induction of endoplasmic reticulum stress.
AuthorsRicha Tiwary, Weiping Yu, Linda A deGraffenried, Bob G Sanders, Kimberly Kline
JournalBreast cancer research : BCR (Breast Cancer Res) Vol. 13 Issue 6 Pg. R120 ( 2011) ISSN: 1465-542X [Electronic] England
PMID22115051 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Hormonal
  • Antioxidants
  • beta-Cyclodextrins
  • methyl-beta-cyclodextrin
  • Tamoxifen
  • Cholesterol
  • alpha-Tocopherol
Topics
  • Antineoplastic Agents, Hormonal (pharmacology, therapeutic use)
  • Antioxidants (pharmacology)
  • Apoptosis (drug effects)
  • Breast Neoplasms (drug therapy, metabolism)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Cholesterol (metabolism)
  • Drug Resistance, Neoplasm
  • Female
  • Humans
  • Membrane Microdomains (drug effects, metabolism)
  • Signal Transduction (drug effects)
  • Tamoxifen (pharmacology, therapeutic use)
  • alpha-Tocopherol (pharmacology)
  • beta-Cyclodextrins (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: